Company: ATRA
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059322
Chunk: 39

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 39
---
 by the reporting person on February 6, 2025. The Schedule 13G provides information as of January 30, 2025 and, consequently, the beneficial ownership of the reporting person may have changed between January 30, 2025 and March 14, 2025. As of January 30, 2025, Panacea Venture Healthcare Fund II, L.P (“Panacea”) and James Huang (“Huang”) held shared voting power and shared dispositive power over 550,000 of such shares. The address of each of the foregoing entities is Maples Corporate Services Limited, Ugland House, Grand Cayman KY1-1104, Cayman Islands.

The indicated ownership is based solely on a Schedule 13G/A filed with the SEC by the reporting person on September 13, 2024. The Schedule 13G/A provides information as of September 3, 2024 and, consequently, the beneficial ownership of the reporting person may have changed between September 3, 2024 and March 14, 2025. As reported on such Schedule 13G/A, as of September 3, 2024, Redmile Group, LLC’s (“Redmile”) beneficial ownership comprised of 579,541 shares owned by certain private investment vehicles and/or separately managed accounts managed by Redmile, which shares may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and/or separately managed accounts. The shares may also be deemed beneficially owned by Jeremy C. Green as the principal of Redmile. Redmile and Mr. Green each disclaim beneficial ownership of these shares, except to the extent of its or his pecuniary interest in such shares, if any. Redmile may also be deemed to beneficially own 2,740,681 shares of common stock issuable upon exercise of certain pre-funded warrants to purchase shares of common stock (the “Warrants”). Pursuant to the terms of the Warrants, the Company may not effect any exercise of any Warrant, and a holder of a Warrant does not have the right to exercise any portion of the Warrant held by such holder, to the extent that, after giving effect to the attempted exercise set forth in a notice of exercise, such holder, together with such holder’s affiliates and any other person whose beneficial ownership of the Common Stock would be aggregated with such holder’s for the purposes of Section 13(d) of the Exchange Act, and the applicable regulations of the SEC, including any